Genetic susceptibility to ischemic stroke

Nature Reviews Neurology

Volumn 7, Issue 7, 2011, Pages 369-378

  Meschia, James F ^a   Worrall, Bradford B ^b   Rich, Stephen S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NOTCH3 RECEPTOR; ORGANIC ANION TRANSPORTER 2; PLACEBO; PRASUGREL; TICAGRELOR; WARFARIN;

ACUTE CORONARY SYNDROME; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CADASIL; CAROTID ATHEROSCLEROSIS; CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCT AND LEUKOENCEPHALOPATHY; DRUG SAFETY; FABRY DISEASE; FAMILIAL DISEASE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART ATRIUM FIBRILLATION; HUMAN; LEUKOARAIOSIS; LEUKODYSTROPHY; MELAS SYNDROME; MYALGIA; MYOPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOGENOMICS; PRIORITY JOURNAL; RETINA DISEASE; RETINAL VASCULOPATHY WITH CEREBRAL LEUKODYSTROPHY; REVIEW; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; CADASIL; FABRY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ISCHEMIA; PHARMACOGENETICS; STROKE;

EID: 79960081642     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.80     Document Type: Review

References (93)

1. Roger, V. L. et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18-e209 (2011
2. Flossmann, E., Schulz, U. G. & Rothwell, P. M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35, 212-227 (2004 (Pubitemid 38057622)
3. Goldstein, J. L. & Brown, M. S. Molecular medicine. The cholesterol quartet. Science 292, 1310-1312 (2001
4. Reyes, S. et al. Apathy: a major symptom in CADASIL. Neurology 72, 905-910 (2009
5. Monet-Leprêtre, M. et al. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. Brain 132, 1601-1612 (2009
6. Tikka, S. et al. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain 132, 933-939 (2009
7. Joutel, A. et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358, 2049-2051 (2001 (Pubitemid 34084832)
8. Singhal, S., Rich, P. & Markus, H. S. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. AJNR Am. J. Neuroradiol. 26, 2481-2487 (2005
9. Liem, M. K. et al. MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study. Neurology 72, 143-148 (2009
10. Hara, K. et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N. Engl. J. Med. 360, 1729-1739 (2009
11. Mendioroz, M. et al. A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology 75, 2033-2035 (2010
12. Fellgiebel, A., Müller, M. J. & Ginsberg, L. CNS manifestations of Fabrys disease. Lancet Neurol. 5, 791-795 (2006
13. Sims, K., Politei, J., Banikazemi, M. & Lee, P. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40, 788-794 (2009
14. Mehta, A. et al. Enzyme replacement therapy with agalsidase alfa in patients with Fabrys disease: an analysis of registry data. Lancet 374, 1986-1996 (2009
15. Rolfs, A. et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366, 1794-1796 (2005 (Pubitemid 41642643)
16. Wozniak, M. A. et al. Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke. Stroke 41, 78-81 (2010
17. Baptista, M. V. et al. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study- screening genetic conditions in Portuguese young stroke patients. Stroke 41, 431-436 (2010
18. Brouns, R. et al. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1,000 young patients with cerebrovascular disease. Stroke 41, 863-868 (2010
19. Richards, A. et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet. 39, 1068-1070 (2007 (Pubitemid 47340644)
20. Mateen, F. J. et al. Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation. Neurology 75, 1211-1213 (2010
21. Kernt, M., Gschwendtner, A., Neubauer, A. S., Dichgans, M. & Haritoglou, C. Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy. J. Neurol. 257, 1213-1214 (2010
22. Desai, D. & Dhanani, H. Sickle cell disease: history and origin. The Internet Journal of Hematology [online], http://www.ispub.com/ostia/index.php? xmlFilePath=journals/ijhe/vol1n2/sickle.xml#h1-0 (2004
23. Oner, C. et al. Beta S haplotypes in various world populations. Hum. Genet. 89, 99-104 (1992
24. Lemos Cardoso, G. & Farias Guerreiro, J. African gene flow to north Brazil as revealed by HBB S. gene haplotype analysis. Am. J. Hum. Biol. 18, 93-98 (2006
25. Rahimi, Z., Merat, A., Gerard, N., Krishnamoorthy, R. & Nagel, R. L. Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum. Biol. 78, 719-731 (2006 (Pubitemid 47164651)
26. Ohene-Frempong, K. et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91, 288-294 (1998 (Pubitemid 28018756)
27. Lee, M. T. et al. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 108, 847-852 (2006 (Pubitemid 44154616)
28. Sebastiani, P., Ramoni, M. F., Nolan, V., Baldwin, C. T. & Steinberg, M. H. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat. Genet. 37, 435-440 (2005
29. Taylor VI, J. G. et al. Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100, 4303-4309 (2002 (Pubitemid 35429667)
30. Seshadri, S. et al. Parental occurrence of stroke and risk of stroke in their children: the Framingham study. Circulation 121, 1304-1312 (2010
31. MacClellan, L. R. et al. Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study. Genet. Epidemiol. 30, 602-608 (2006 (Pubitemid 44630930)
32. Jerrard-Dunne, P., Cloud, G., Hassan, A. & Markus, H. S. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 34, 1364-1369 (2003 (Pubitemid 36693499)
33. Schulz, U. G., Flossmann, E. & Rothwell, P. M. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 35, 819-824 (2004 (Pubitemid 38419784)
34. Meschia, J. F. Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research. Stroke 33, 2770-2774 (2002 (Pubitemid 35462842)
35. Dichgans, M. & Markus, H. S. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 36, 2027-2031 (2005 (Pubitemid 41266548)
36. Luke, M. M. et al. Gene variants associated with ischemic stroke: the cardiovascular health study. Stroke 40, 363-368 (2009
37. Matarin, M. et al. Candidate gene polymorphisms for ischemic stroke. Stroke 40, 3436-3442 (2009
38. Casas, J. P., Hingorani, A. D., Bautista, L. E. & Sharma, P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. 61, 1652-1661 (2004 (Pubitemid 39463422)
39. Wang, X. et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40, 683-695 (2009
40. Ariyaratnam, R. et al. Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med. 4, e131 (2007
41. Xin, X. Y. et al. Gene polymorphisms and risk of adult early-onset ischemic stroke: a meta-analysis. Thromb. Res. 124, 619-624 (2009
42. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131-138 (2003 (Pubitemid 37187631)
43. Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233-239 (2004 (Pubitemid 38282747)
44. Bevan, S. et al. Variation in the PDE4D gene and ischemic stroke risk: a systematic review and meta-analysis on 5,200 cases and 6,600 controls. Stroke 39, 1966-1971 (2008
45. Zintzaras, E., Rodopoulou, P. & Sakellaridis, N. Variants of the arachidonate 5-lipoxygenase- activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis. Am. J. Epidemiol. 169, 523-532 (2009
46. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488-1491 (2007 (Pubitemid 46906617)
47. Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493 (2007 (Pubitemid 46906618)
48. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007
49. Samani, N. J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007 (Pubitemid 47204873)
50. Gschwendtner, A. et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann. Neurol. 65, 531-539 (2009
51. Gretarsdottir, S. et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann. Neurol. 64, 402-409 (2008
52. Lemmens, R. et al. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke 41, 1850-1857 (2010
53. Gudbjartsson, D. F. et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat. Genet. 41, 876-878 (2009
54. Ikram, M. A. et al. Genomewide association studies of stroke. N. Engl. J. Med. 360, 1718-1728 (2009
55. International Stroke Genetics Consortium; Wellcome Trust Case-Control Consortium 2. Failure to validate association between 12p13 variants and ischemic stroke. N. Engl. J. Med. 362, 1547-1550 (2010
56. Anderson, C. D. et al. The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ. Cardiovasc. Genet. 4, 188-196 (2011
57. Yamada, Y. et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 207, 144-149 (2009
58. Lanktree, M. B., Dichgans, M. & Hegele, R. A. Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41, 825-832 (2010
59. Anderson, C. D. et al. Common mitochondrial sequence variants in ischemic stroke. Ann. Neurol. 69, 471-480 (2010
60. Chinnery, P. F., Elliott, H. R., Syed, A. & Rothwell, P. M. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study. Lancet Neurol. 9, 498-503 (2010
61. Rosa, A. et al. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med. Genet. 9, 57 (2008
62. Nishigaki, Y. et al. Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females. Mitochondrion 7, 72-79 (2007 (Pubitemid 46351955)
63. Benn, M., Schwartz, M., Nordestgaard, B. G. & Tybjaerg-Hansen, A. Mitochondrial haplogroups: ischemic cerebrovascular disease, other diseases, mortality, and longevity in the general population. Circulation 117, 2492-2501 (2008 (Pubitemid 351670456)
64. Jood, K., Ladenvall, C., Rosengren, A., Blomstrand, C. & Jern, C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 36, 1383-1387 (2005 (Pubitemid 40967498)
65. FDA Announces new boxed warning on Plavix. FDA [online]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm204253.htm2010)
66. Mega, J. L. et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis. Lancet 376, 1312-1319 (2010
67. Wallentin, L. et al. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial. Lancet 376, 1320-1328 (2010
68. Paré, G. et al. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N. Engl. J. Med. 363, 1704-1714 (2010
69. Klein, T. E. et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360, 753-764 (2009
70. Tan, G. M., Wu, E., Lam, Y. Y. & Yan, B. P. Role of warfarin pharmacogenetic testing in clinical practice. Pharmacogenomics 11, 439-448 (2010
71. Link, E. et al. SLCO1B1 variants and statin-induced myopathy-a genomewide study. N. Engl. J. Med. 359, 789-799 (2008
72. Voora, D. et al. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J. Am. Coll. Cardiol. 54, 1609-1616 (2009
73. Table of pharmacogenomic biomakers in drug labels. FDA [online] www.fda.gov/Drugs/scienceresearch/researchAreas/pharmacogenetics/ucm083378. htm(2011).
74. Gershon, E. S. & Goldin, L. R. Clinical methods in psychiatric genetics. I. Robustness of genetic marker investigative strategies. Acta Psychiatr. Scand. 74, 113-118 (1986 (Pubitemid 16022153)
75. Dong, C. et al. Genomewide linkage and peakwide association analyses of carotid plaque in Caribbean Hispanics. Stroke 41, 2750-2756 (2010
76. Belfer, I. et al. Linkage of large-vessel carotid atherosclerotic stroke to inflammatory genes via a systematic screen. Int. J. Stroke 5, 145-151 (2010
77. Sacco, R. L. et al. Heritability and linkage analysis for carotid intima-media thickness: the Family Study of Stroke Risk and Carotid Atherosclerosis. Stroke 40, 2307-2312 (2009
78. ODonnell, C. et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBIs Framingham Heart Study. BMC Med. Genet. 8 (Suppl. 1), S4 (2007
79. Debette, S. & Markus, H. S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341, c3666 (2010
80. Carmelli, D. et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 29, 1177-1181 (1998 (Pubitemid 28265474)
81. Atwood, L. D. et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 35, 1609-1613 (2004 (Pubitemid 38823634)
82. Turner, S. T. et al. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 43, 483-487 (2004 (Pubitemid 38174158)
83. Paternoster, L., Chen, W. & Sudlow, C. L. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 40, 2020-2026 (2009
84. Turner, S. T. et al. Genomic susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch. Neurol. 66, 847-857 (2009
85. Debette, S. et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 41, 210-217 (2010
86. dbSNP. National Center for Biotechnology Information [online] http://www.ncbi.nlm.nih.gov/projects/SNP/(2011).
87. International HapMap Project. National Center for Biotechnology Information [online], http://hapmap.ncbi.nlm.nih.gov/ (2011
88. 1000 Genomes Project. 1000 Genomes [online], http://www.1000genomes.org/ (2011
89. Ng, S. B., Nickerson, D. A., Bamshad, M. J. & Shendure, J. Massively parallel sequencing and rare disease. Hum. Mol. Genet. 19, R119-R124 (2010
90. The NINDS Stroke Genetics Network (SiGN) study. University of Maryland School of Medicine [online] http://strokegenetics.som.umaryland.edu/stroke(2011)
91. Causative classification system for ischemic stroke (CCS-Stroke Genetics). The General Hospital Corporation [online], http://ccs-stroke.org/ StrokeGenetics (2011
92. dbGAP. National Center for Biotechnology Information [online] http://www.ncbi.nlm.nih.gov/gap(2011)
93. Genomics and randomized trials network. Collaborative Health Studies Coordinating Center, University of Washington [online] http://www.garnetstudy. org(2011)